These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 84325)

  • 41. [Biochemical activity and drug sensitivity of Mycobacterium tuberculosis in selected forms of pulmonary tuberculosis].
    Polz MA; Jabłoński L; Wypych M
    Pneumonol Pol; 1985 Oct; 53(10):482-6. PubMed ID: 3938011
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM; Shrentsel' OA
    Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
    [No Abstract]   [Full Text] [Related]  

  • 43. [Bacteriological and clinical aspects of the restoration of drug sensitivity of formerly resistant Mycobacterium cultures].
    Rudoĭ NM; Bochkov EN
    Probl Tuberk; 1973; 51(10):24-6. PubMed ID: 4206103
    [No Abstract]   [Full Text] [Related]  

  • 44. [Case of primary poly-drug resistance of mycobacteria from a 70-year-old tuberculosis patient].
    Deribas TB
    Probl Tuberk; 1985; (11):67-8. PubMed ID: 3936033
    [No Abstract]   [Full Text] [Related]  

  • 45. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 46. [A study of prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patients in 1972. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].
    Gomi J; Chiba Y; Yanagisawa K
    Kekkaku; 1975 Feb; 50(2):55-62. PubMed ID: 815707
    [No Abstract]   [Full Text] [Related]  

  • 47. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Polyresistance of Mycobacterium].
    Terentieva AS; Tsvelev EV
    Vrach Delo; 1981 Nov; (11):85-6. PubMed ID: 6805134
    [No Abstract]   [Full Text] [Related]  

  • 50. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current data on primary resistance in pulmonary tuberculosis in adults in France. 2d survey of the Centre d'Etudes sur la Resistance Primaire: 1965-1966].
    Canetti G; Kreis B; Thibier R; Gay P; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1967 Jun; 31(4):433-74. PubMed ID: 4974609
    [No Abstract]   [Full Text] [Related]  

  • 52. Mycobacterium tuberculosis drug resistance, Ghana.
    Owusu-Dabo E; Adjei O; Meyer CG; Horstmann RD; Enimil A; Kruppa TF; Bonsu F; Browne EN; Chinbuah MA; Osei I; Gyapong J; Berberich C; Kubica T; Niemann S; Ruesch-Gerdes S
    Emerg Infect Dis; 2006 Jul; 12(7):1171-2. PubMed ID: 16848046
    [No Abstract]   [Full Text] [Related]  

  • 53. Reduction of drug resistance of mycobacterium tuberculosis after treatment with hamycin.
    Panse MV; Narayanan RA; Sathe PM
    Indian J Med Res; 1974 Sep; 62(9):1360-6. PubMed ID: 4216575
    [No Abstract]   [Full Text] [Related]  

  • 54. A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis.
    Collins FM; Mackaness GB; Montalbine V; Smith MM
    Am Rev Respir Dis; 1968 Aug; 98(2):189-200. PubMed ID: 4174476
    [No Abstract]   [Full Text] [Related]  

  • 55. [Mycobacterial drug resistance in patients with pulmonary tuberculosis].
    Georgescu M; Lazanu DM; Petreanu C
    Rev Med Chir Soc Med Nat Iasi; 1991; 95(1-2):67-70. PubMed ID: 1823431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [IZOPASK®--THE NEW COMBINED ANTITUBERCULAR PREPARATION].
    Tuberk Biolezni Legkih; 2010; (4):61-4. PubMed ID: 27534031
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical study on relapse cases of pulmonary tuberculosis].
    Takikawa S
    Kekkaku; 2009 Dec; 84(12):769-72. PubMed ID: 20491146
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of mixtures of atabrine and antibacterial agents on the emergence of resistant strains of Mycobacterium tuberculosis.
    Warren GH; Gregory FJ; Healy EM; Flint SF
    Nature; 1967 Jul; 215(5100):526-7. PubMed ID: 4168326
    [No Abstract]   [Full Text] [Related]  

  • 59. [In vitro antituberculous activity of lividomycin].
    Kobayashi F; Nagoya T; Eda J; Yoshimura Y
    Jpn J Antibiot; 1972 Dec; 25(6):360-6. PubMed ID: 4125073
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug resistant tuberculosis in a large southern California hospital.
    Schiffman PL; Ashkar B; Bishop M; Cleary MG
    Am Rev Respir Dis; 1977 Nov; 116(5):821-5. PubMed ID: 411406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.